Another aspect is related to impact of anti-tumor compounds on CP-mediated DNA damage, so that by increasing ROS levels, anti-tumor compounds enhance p53 phosphorylation to induce DNA damage and cell death [226]. The gene discussed is CP; the disease is neoplasm.